Friday, 20 November 2026Read the signal. Shape what comes next.
Higher Ed Signal
Get the Signal Brief
Panoramic view of the University Hospital Essen campus, with white and yellow clinic towers and low-rise buildings rising above green trees under a pale sky.

Institutional development · Research collaboration · Germany

New Leibniz campus links ISAS and Duisburg-Essen to study heart harm from cancer therapy

A Leibniz Cardio-Oncology Campus for Precision Medicine pairs ISAS with the University of Duisburg-Essen and its hospital to find ways of spotting and averting cardiovascular injury caused by cancer treatment.

Photo: Tuxyso / Wikimedia Commons, CC BY-SA 3.0

Why it matters: Heart and cancer specialists and scientists at ISAS, the University of Duisburg-Essen and University Hospital Essen are now working jointly on treatment-related cardiovascular injury.

The newly created Leibniz Cardio-Oncology Campus for Precision Medicine unites heart specialists, cancer specialists and scientists from ISAS, the Leibniz Institute for Analytical Sciences, and from the University of Duisburg-Essen, whose University Hospital Essen also takes part.

The announcement states that chemotherapy and immunotherapy can inflict lasting harm on the heart and blood vessels, with consequences that may threaten patients' lives.

According to the partners, this is the first time scientists and clinicians have teamed up to study how such harm might be identified at an early stage and avoided.

Editor’s view

Joseph Lopez, Collaboration Editor

For ISAS, the University of Duisburg-Essen and University Hospital Essen, the campus sets a shared agenda: finding early signs of cardiovascular injury from chemotherapy and immunotherapy and ways to prevent it.

Keep reading

See all